Covered recipient · General Payments record
JOSEPH KEVIN PIDKOWICZ
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2018–2022
$3,686.10
- Reported across 186 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2022 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $598.47 | 30 |
By paying entity
PY2022 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $256.74 | 13 |
| Lilly USA, LLC | $72.03 | 3 |
| Amgen Inc. | $70.45 | 3 |
| LEO Pharma Inc. | $52.34 | 3 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $45.22 | 2 |
| GENZYME CORPORATION | $40.84 | 2 |
| Incyte Corporation | $30.80 | 2 |
| MISSION PHARMACAL COMPANY | $17.07 | 1 |
| Galderma Laboratories, L.P. | $12.98 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2022 (30)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $27.52 | 01/25/2022 | Food and Beverage | Undisputed | 01/23/2026 | 891366501 | CMS |
| ABBVIE INC. | $19.46 | 02/15/2022 | Food and Beverage | Undisputed | 01/23/2026 | 891366503 | CMS |
| ABBVIE INC. | $25.91 | 03/31/2022 | Food and Beverage | Undisputed | 01/23/2026 | 891366505 | CMS |
| ABBVIE INC. | $29.98 | 04/11/2022 | Food and Beverage | Undisputed | 01/23/2026 | 891366507 | CMS |
| ABBVIE INC. | $11.65 | 04/19/2022 | Food and Beverage | Undisputed | 01/23/2026 | 891366509 | CMS |
| ABBVIE INC. | $11.89 | 05/03/2022 | Food and Beverage | Undisputed | 01/23/2026 | 891366511 | CMS |
| ABBVIE INC. | $19.32 | 05/17/2022 | Food and Beverage | Undisputed | 01/23/2026 | 891366513 | CMS |
| ABBVIE INC. | $18.87 | 06/14/2022 | Food and Beverage | Undisputed | 01/23/2026 | 891366515 | CMS |
| ABBVIE INC. | $28.60 | 07/14/2022 | Food and Beverage | Undisputed | 01/23/2026 | 891366517 | CMS |
| ABBVIE INC. | $10.42 | 08/01/2022 | Food and Beverage | Undisputed | 01/23/2026 | 891366519 | CMS |
| ABBVIE INC. | $17.20 | 08/09/2022 | Food and Beverage | Undisputed | 01/23/2026 | 891366521 | CMS |
| ABBVIE INC. | $26.42 | 08/16/2022 | Food and Beverage | Undisputed | 01/23/2026 | 891366523 | CMS |
| ABBVIE INC. | $9.50 | 10/18/2022 | Food and Beverage | Undisputed | 01/23/2026 | 891366525 | CMS |
| Amgen Inc. | $19.40 | 01/11/2022 | Food and Beverage | Undisputed | 01/23/2026 | 939938151 | CMS |
| Amgen Inc. | $26.17 | 04/28/2022 | Food and Beverage | Undisputed | 01/23/2026 | 939938153 | CMS |
| Amgen Inc. | $24.88 | 08/09/2022 | Food and Beverage | Undisputed | 01/23/2026 | 939938155 | CMS |
| Galderma Laboratories, L.P. | $12.98 | 05/16/2022 | Food and Beverage | Undisputed | 01/23/2026 | 952290835 | CMS |
| GENZYME CORPORATION | $16.32 | 04/12/2022 | Food and Beverage | Undisputed | 01/23/2026 | 938822843 | CMS |
| GENZYME CORPORATION | $24.52 | 06/16/2022 | Food and Beverage | Undisputed | 01/23/2026 | 938822867 | CMS |
| Incyte Corporation | $13.33 | 01/05/2022 | Food and Beverage | Undisputed | 01/23/2026 | 943072515 | CMS |
| Incyte Corporation | $17.47 | 03/22/2022 | Food and Beverage | Undisputed | 01/23/2026 | 943072593 | CMS |
| LEO Pharma Inc. | $11.84 | 01/14/2022 | Food and Beverage | Undisputed | 01/23/2026 | 936268185 | CMS |
| LEO Pharma Inc. | $21.09 | 01/14/2022 | Food and Beverage | Undisputed | 01/23/2026 | 936268191 | CMS |
| LEO Pharma Inc. | $19.41 | 08/10/2022 | Food and Beverage | Undisputed | 01/23/2026 | 936268197 | CMS |
| Lilly USA, LLC | $23.67 | 06/14/2022 | Food and Beverage | Undisputed | 01/23/2026 | 918109105 | CMS |
| Lilly USA, LLC | $20.39 | 07/19/2022 | Food and Beverage | Undisputed | 01/23/2026 | 918170723 | CMS |
| Lilly USA, LLC | $27.97 | 08/04/2022 | Food and Beverage | Undisputed | 01/23/2026 | 918129541 | CMS |
| Mission Pharmacal Company | $17.07 | 07/01/2022 | Food and Beverage | Undisputed | 01/23/2026 | 861437161 | CMS |
| Sun Pharmaceutical Industries Inc. | $15.49 | 02/28/2022 | Food and Beverage | Undisputed | 01/23/2026 | 947806687 | CMS |
| Sun Pharmaceutical Industries Inc. | $29.73 | 06/28/2022 | Food and Beverage | Undisputed | 01/23/2026 | 947806691 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022
- Generated from
- OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.